Use of Demineralized bone matrix to increase healing capacity in management of Atypical femoral fracture

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171028001

Enrollment

Registered

2017-10-28

Start date

2016-03-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atypical femoral fracture Demineralized bone matrix Delay union Atypical femoral fracture Demineralized bone matrix Delay union

Interventions

Intramedullary fixation Stop bisphosphonate Correct blood minerals,Intramedullary fixation with DBM injection at the fracture site Stop bisphosphonate Correct blood minerals

Active Comparator Procedure/Surgery,Experimental Drug

Control group,DBM group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Be diagnosed as atypical femoral fracture by ASBMR 2013 2.Willing to participate

Exclusion criteria

Exclusion criteria: 1.Contraindicate to surgery 2.Open fracture 3.Receive prior surgery

Design outcomes

Primary

Measure	Time frame
union time every 6 weeks clinical & radiograph	—

Secondary

Measure	Time frame
complication rate pos-operative, every 6 weeks clinical & radiograph	—

Countries

Thailand

Contacts

Public ContactKonlawat Sabsuantang

Faculty of Medicine, Ramathibodi hospital, Mahidol university

Konlawat_s@hotmail.com0865639894

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026